Related Transaction Announcement
Stock code: 832316 Securities abbreviation: Tim Biotech Host brokerage: Shenwan Hongyuan underwriting sponsor
Jilin Tianzheng Biotechnology Co., Ltd
Announcement of related party transactions
The Company and all members of the Board of Directors warrant that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume individual responsibility for the authenticity, accuracy and completeness of the contentWith legal liability.
I. Overview of Related Party Transactions
(1) Overview of related party transactions
Jilin Tianzheng Biotechnology Co., Ltd. intends to lease Cai Tiyuan's house at No. 88, Building 3 [Building], Hongcheng International Garden Community, No. 1805 Southeast Lake Road, Nanguan District, Changchun City, with a transaction amount of 412 square meters12,00 yuan/year.
(2) Voting and deliberation
The 3th meeting of the third board of directors of the company deliberated and passed the "Motion on Cai Tiyuan Leasing His Own House to Jilin Tianzheng Biotechnology Co., Ltd.", and the voting results: 0 votes in favor, 0 votes against, abstained2 votes, 2022 abstentions. Recusal from voting: Cai Tiyuan is the controlling shareholder and actual controller of the company, and Cai Tiyuan and director Cai Timing are brothers, so Cai Tiyuan and Cai Timing are affiliated directors and recused themselves from voting. The above proposals are subject to consideration at the <> Annual General Meeting of Shareholders.
(3) There is no circumstance that this related party transaction requires approval from the relevant departments
2. Basic information of the coalition
1. Natural persons
Name: Cai Tiyuan
Residence: Changchun City Nanguan District Hongcheng Street Water Purification Road Committee * Group
Affiliation: Controlling Shareholder and Actual Controller Announcement No.: 2023-012
Credit situation: not a dishonest person subject to enforcement
(1) Pricing basis
Cai Tiyuan, a related party, leased his own house to Jilin Tian Zheng Biotechnology Co., Ltd. to meet the company's business needs. After negotiation between the two parties, the rent is determined according to the market price. The related party transaction did not harm the interests of the company and other shareholders, and its behavior did not violate the relevant pricing policy.
(2) Fairness of transaction pricing
The transaction pricing between the company and related parties is determined in accordance with the principle of fair and equitable market, on the basis of truthful and full expression of their respective wishes, and has no adverse effect on the company's ability to continue operations, profit and loss and asset statusThere is a situation that harms the interests of the company and other shareholders.
4. Main contents of the transaction agreement
The transaction agreement has not yet been signed, and if there is a significant change in the content of the signed agreement and the content of this disclosure, the relevant progress announcement will be disclosed.
5. The purpose, risks and impact on the company of the related party transaction
(1) The purpose of this related party transaction
The above-mentioned related party transactions are normal transactions of the company, which are normal needs of the company's business development and production and operation, and are reasonable and necessary. The related party transactions between the company and related parties follow the principle of market fairness, do not harm the interests of the company and the company's shareholders, and will not rely on related parties due to the above-mentioned related party transactions.
(2) The risks existing in this related party transaction
The pricing of related party transactions between the company and related parties is fair and reasonable, does not harm the interests of the company's shareholders, and will not adversely affect the company's independence.
(3) The impact of the related party transaction on the company's operations and finances
Related party transactions between the Company and related parties will not adversely affect the Company's financial condition and results of operations.
6. Catalog of documents for reference
"Resolution of the 17th Meeting of the Third Board of Directors of Jilin Tianzheng Biotechnology Co., Ltd."
Jilin Tianzheng Biotechnology Co., Ltd
board of directors
June 2023, 4